Blood Donors Clinical Trial
Official title:
Obstetrical History and Anti-HLA Antibodies Level
Chronic histiocytic intervillositis (CHI) is associated with severe and recurrent obstetrical complications. A link between anti-HLA Antibodies (Ab) and CHI has recently been established. At the Etablissement Français du Sang (EFS), donors who have already given birth once and have high levels of anti-HLA are excluded from donating apheresis platelets and therapeutic plasma to prevent TRALI (Transfusion Related Acute Lung Injury). No studies have examined the obstetrical history of these donors. The question is: is there an association between anti-HLA levels and obstetrical complications?
Chronic histiocytic intervillositis (CHI) is a rare condition with an incidence of around 5 in 10,000 pregnancies. It is defined by major infiltration of the intervillous cavity by CD68+ maternal histiocytes, associated with fibrin deposition on the villous surface. CHI is associated with severe obstetrical complications and a very high recurrence rate, estimated at between 70% and 100%. These complications include early and late miscarriage, fetal death, severe growth retardation in surviving fetuses, and premature delivery. The survival rate reported in the literature varies between 30% and 50%. Anti-HLA antibodies are present in 54% of pregnant women at the end of pregnancy, and their rate increases towards the end of pregnancy. The presence of HLA antibodies also increases with the number of pregnancies, and is found in up to 74% of cases after more than 2 deliveries. The research question concerns the existence of a statistically significant association between the presence of high levels of anti-HLA antibodies and the occurrence of one or more obstetric complications. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00097006 -
Retrovirus Epidemiology Donor Study-II (REDS-II)
|
N/A | |
| Completed |
NCT00005721 -
Retaining Donors and Increasing Donation Frequency
|
N/A | |
| Recruiting |
NCT04078893 -
The Effect of Recruiting Inactive Blood Donors Using Different Means
|
N/A | |
| Completed |
NCT02274064 -
Motivating Type O- Blood Donors to Return
|
N/A | |
| Completed |
NCT04783077 -
Community-Based Communication Approaches for Blood Donation in Ghana
|
N/A | |
| Completed |
NCT02717338 -
Blood Donor Competence, Autonomy and Relatedness Enhancement
|
Phase 3 | |
| Completed |
NCT01104740 -
Dengue Seroprevalence Study in Blood Donors in the French West Indies
|
||
| Completed |
NCT03988738 -
Promoting Repeat Blood Donation Through Social Media Among First-time Donors in a Peruvian Blood Bank
|
N/A | |
| Completed |
NCT04088695 -
Effect of a Web Page Based on a Motivational Video for Voluntary Blood Donation
|
N/A | |
| Completed |
NCT00005278 -
Retrovirus Epidemiology Donor Study I (REDS I)
|
N/A | |
| Recruiting |
NCT00001846 -
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
|
||
| Completed |
NCT00005339 -
Risk of Post Transfusion Hepatitis C Virus Infection
|
N/A | |
| Terminated |
NCT00005341 -
Blood Donation--Immune Sequelae and Recruitment
|
||
| Completed |
NCT03835299 -
Addressing Fear and Risk of Vasovagal Reactions Among High School Donors
|
N/A | |
| Completed |
NCT00005360 -
HIV Diversity and Pathogenesis in Donor-Recipient Clusters
|
N/A | |
| Completed |
NCT03102385 -
A Survey of Attitudes of Experienced Blood Donors
|
N/A | |
| Completed |
NCT02145507 -
Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution
|
Phase 1 | |
| Completed |
NCT00029406 -
Transfusion Infections Pediatric Prospective Study (TRIPPS)
|
N/A | |
| Completed |
NCT00006310 -
KSHV Infection in Blood Donors From Texas
|
N/A |